Compound ID | 1934
Class: Beta-lactam (ureidopenicillin)
| Spectrum of activity: | Gram-positive & Gram-negative | 
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive and some Gram-negative bacteria including Pseudomonas aeruginosa, but vulnerable to beta-lactamases | 
| Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA). Closely related to azlocillin. Parenteral application | 
| Institute where first reported: | BAYER | 
| Year first mentioned: | 1976 | 
| Highest developmental phase: | Approved by FDA in 1981 | 
| Development status: | Discontinued | 
| Chemical structure(s): | |||||||||||
                               
  | 
                                               
                                               
                                               
                                               
                           
                           
                               
  | 
                                       
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/656511 | 
| Guide to Pharmacology: | mezlocillin | 
| Citations: | 
                                        
                                            
                                                
                                                
                                                     |